| Year |
Citation |
Score |
| 2008 |
Perry G, Cash AD, Harris PL, Siedlak SL, Smith MA, Zhu X. P4-170: Peroxidative nitrotyrosine formation in Alzheimer's disease Alzheimer's & Dementia. 4: T720-T720. DOI: 10.1016/J.Jalz.2008.05.2237 |
0.628 |
|
| 2006 |
Zhu X, Perry G, Moreira PI, Aliev G, Cash AD, Hirai K, Smith MA. Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. Journal of Alzheimer's Disease : Jad. 9: 147-53. PMID 16873962 DOI: 10.3233/JAD-2006-9207 |
0.773 |
|
| 2005 |
Liu Q, Lee HG, Honda K, Siedlak SL, Harris PL, Cash AD, Zhu X, Avila J, Nunomura A, Takeda A, Smith MA, Perry G. Tau modifiers as therapeutic targets for Alzheimer's disease. Biochimica Et Biophysica Acta. 1739: 211-5. PMID 15615639 DOI: 10.1016/J.Bbadis.2004.06.021 |
0.832 |
|
| 2005 |
Moreira PI, Siedlak SL, Aliev G, Zhu X, Cash AD, Smith MA, Perry G. Oxidative stress mechanisms and potential therapeutics in Alzheimer disease. Journal of Neural Transmission (Vienna, Austria : 1996). 112: 921-32. PMID 15583960 DOI: 10.1007/S00702-004-0242-8 |
0.784 |
|
| 2004 |
Castellani RJ, Honda K, Zhu X, Cash AD, Nunomura A, Perry G, Smith MA. Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease. Ageing Research Reviews. 3: 319-26. PMID 15231239 DOI: 10.1016/j.arr.2004.01.002 |
0.822 |
|
| 2004 |
Casadesus G, Smith MA, Zhu X, Aliev G, Cash AD, Honda K, Petersen RB, Perry G. Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. Journal of Alzheimer's Disease : Jad. 6: 165-9. PMID 15096700 DOI: 10.3233/Jad-2004-6208 |
0.842 |
|
| 2004 |
Cash A, Smith M, Perry G. Oxidative Stress Mechanisms and Potential Therapeutic Modalities in Alzheimer Disease Medicinal Chemistry Reviews - Online. 1: 19-23. DOI: 10.2174/1567203043480386 |
0.673 |
|
| 2003 |
Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, Zhu X, Raina AK, Vinters HV, Tabaton M, Johnson AB, Paula-Barbosa M, AvÃla J, Jones PK, Castellani RJ, Smith MA, et al. Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. The American Journal of Pathology. 162: 1623-7. PMID 12707046 DOI: 10.1016/S0002-9440(10)64296-4 |
0.789 |
|
| 2003 |
Raina AK, Hochman A, Ickes H, Zhu X, Ogawa O, Cash AD, Shimohama S, Perry G, Smith MA. Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out? Progress in Neuro-Psychopharmacology & Biological Psychiatry. 27: 251-4. PMID 12657364 DOI: 10.1016/S0278-5846(03)00020-4 |
0.606 |
|
| 2003 |
Perry G, Taddeo MA, Petersen RB, Castellani RJ, Harris PL, Siedlak SL, Cash AD, Liu Q, Nunomura A, Atwood CS, Smith MA. Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. 16: 77-81. PMID 12572666 DOI: 10.1023/A:1020731021276 |
0.765 |
|
| 2003 |
Perry G, Ávila J, Casadesus G, Nunomura A, Tabaton M, Cash A, Aliev G, Wataya T, Shimohama S, Drew K, Atwoo C, Smith M. La función del estrés oxidativo en la patogénesis de la enfermedad de Alzheimer Revista Chilena De Neuro-PsiquiatríA. 41. DOI: 10.4067/S0717-92272003041200006 |
0.729 |
|
| 2003 |
Perry G, Ávila J, Casadesus G, Nunomura A, Tabaton M, Cash A, Aliev G, Wataya T, Shimohama S, Drew K, Atwood C, Smith M. The role of oxidative stress in the pathogenesis of Alzheimer's disease | La función del estrés oxidativo en la patogénesis de la enfermedad de Alzheimer Revista Chilena De Neuro-Psiquiatria. 41: 47-52. |
0.805 |
|
| 2002 |
Perry G, Cash AD, Smith MA. Alzheimer Disease and Oxidative Stress. Journal of Biomedicine & Biotechnology. 2: 120-123. PMID 12488575 DOI: 10.1155/S1110724302203010 |
0.713 |
|
| 2002 |
Perry G, Nunomura A, Cash AD, Taddeo MA, Hirai K, Aliev G, Avila J, Wataya T, Shimohama S, Atwood CS, Smith MA. Reactive oxygen: its sources and significance in Alzheimer disease. Journal of Neural Transmission. Supplementum. 69-75. PMID 12456052 DOI: 10.1007/978-3-7091-6139-5_7 |
0.726 |
|
| 2002 |
Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, Cash AD, Obrenovich ME, Perry G, Smith MA. Role of mitochondrial dysfunction in Alzheimer's disease. Journal of Neuroscience Research. 70: 357-60. PMID 12391597 DOI: 10.1002/Jnr.10389 |
0.809 |
|
| 2002 |
Cash AD, Perry G, Ogawa O, Raina AK, Zhu X, Smith MA. Is Alzheimer's disease a mitochondrial disorder? The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 8: 489-96. PMID 12374431 DOI: 10.1177/107385802236968 |
0.683 |
|
| 2002 |
Cash AD, Perry G, Smith MA. Therapeutic potential in Alzheimer disease. Current Medicinal Chemistry. 9: 1605-10. PMID 12171555 DOI: 10.2174/0929867023369411 |
0.694 |
|
| 2002 |
Perry G, Sayre LM, Atwood CS, Castellani RJ, Cash AD, Rottkamp CA, Smith MA. The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. Cns Drugs. 16: 339-52. PMID 11994023 DOI: 10.2165/00023210-200216050-00006 |
0.715 |
|
| 2002 |
Perry G, Cash AD, Srinivas R, Smith MA. Metals and oxidative homeostasis in Alzheimer's disease Drug Development Research. 56: 293-299. DOI: 10.1002/ddr.10099 |
0.69 |
|
| 2001 |
Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, et al. Mitochondrial abnormalities in Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 3017-23. PMID 11312286 |
0.836 |
|
| 2001 |
Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PLR, Jones PK, et al. Mitochondrial Abnormalities in Alzheimer's Disease The Journal of Neuroscience. 21: 3017-3023. DOI: 10.1523/Jneurosci.21-09-03017.2001 |
0.836 |
|
| Show low-probability matches. |
